Cargando…

Low-Grade Inflammation as a Predictor of Antidepressant and Anti-Inflammatory Therapy Response in MDD Patients: A Systematic Review of the Literature in Combination With an Analysis of Experimental Data Collected in the EU-MOODINFLAME Consortium

Low-grade inflammation plays a role not only in the pathogenesis of major depressive disorder (MDD) but probably also in the poor responsiveness to regular antidepressants. There are also indications that anti-inflammatory agents improve the outcomes of antidepressants. Aim: To study whether the pre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arteaga-Henríquez, Gara, Simon, Maria S., Burger, Bianka, Weidinger, Elif, Wijkhuijs, Annemarie, Arolt, Volker, Birkenhager, Tom K., Musil, Richard, Müller, Norbert, Drexhage, Hemmo A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6630191/ https://www.ncbi.nlm.nih.gov/pubmed/31354538 http://dx.doi.org/10.3389/fpsyt.2019.00458

Ejemplares similares

Efficacy of Sertraline Plus Placebo or Add-On Celecoxib in Major Depressive Disorder: Macrophage Migration Inhibitory Factor as a Promising Biomarker for Remission After Sertraline—Results From a Randomized Controlled Clinical Trial
por: Simon, Maria S., et al.
Publicado: (2021)

Premature T cell aging in major depression: A double hit by the state of disease and cytomegalovirus infection
por: Simon, Maria S., et al.
Publicado: (2023)

S100B Serum Levels Predict Treatment Response in Patients with Melancholic Depression
por: Ambrée, Oliver, et al.
Publicado: (2015)

Childhood trauma, suicide risk and inflammatory phenotypes of depression: insights from monocyte gene expression
por: Schiweck, Carmen, et al.
Publicado: (2020)

Inflammatory activation is associated with a reduced glucocorticoid receptor alpha/beta expression ratio in monocytes of inpatients with melancholic major depressive disorder
por: Carvalho, L A, et al.
Publicado: (2014)

The clinical utility of newer antidepressant agents: Understanding the role in management of MDD
por: Waters, Kristin
Publicado: (2022)

A survey of five antidepressant properties influencing clinician’s treatment choices in MDD
por: Papakostas, George I, et al.
Publicado: (2007)

Effects of Antidepressant Treatment on Peripheral Biomarkers in Patients with Major Depressive Disorder (MDD)
por: Mosiołek, Anna, et al.
Publicado: (2021)

White matter integrity and pro-inflammatory cytokines as predictors of antidepressant response in MDD
por: Breit, S., et al.
Publicado: (2022)

Major Depressive Disorder (MDD) and Antidepressant Medication Are Overrepresented in High-Dose Statin Treatment
por: Leutner, Michael, et al.
Publicado: (2021)

Corrigendum: Major Depressive Disorder (MDD) and Antidepressant Medication Are Overrepresented in High-Dose Statin Treatment
por: Leutner, Michael, et al.
Publicado: (2021)

Major depressive disorder (MDD), antidepressants, and uncontrolled hypertension: A report of intraoperative autonomic dysregulation
por: Paraskeva, Anteia, et al.
Publicado: (2022)

Effects of Antidepressant Treatment on Neurotrophic Factors (BDNF and IGF-1) in Patients with Major Depressive Disorder (MDD)
por: Mosiołek, Anna, et al.
Publicado: (2021)

Why is Diagnosing MDD Challenging?
Publicado: (2016)

Altered resting-state dynamic functional brain networks in major depressive disorder: Findings from the REST-meta-MDD consortium
por: Long, Yicheng, et al.
Publicado: (2020)

Aberrant Resting-State Functional Connectivity in MDD and the Antidepressant Treatment Effect—A 6-Month Follow-Up Study
por: Li, Kangning, et al.
Publicado: (2023)

POSTPARTUM GAD IS A RISK FACTOR FOR POSTPARTUM MDD: THE COURSE AND LONGITUDINAL RELATIONSHIPS OF POSTPARTUM GAD AND MDD
por: Prenoveau, Jason, et al.
Publicado: (2013)

From MDD concepts to experiments and illustrations
por: Babau, Jean-Philippe, et al.
Publicado: (2006)

Reduced serum BDNF levels are associated with the increased risk for developing MDD: a case–control study with or without antidepressant therapy
por: Emon, Md. Prova Zaman, et al.
Publicado: (2020)

The neurocognitive profile of post‐traumatic stress disorder (PTSD), major depressive disorder (MDD), and PTSD with comorbid MDD
por: Koopowitz, Sheri‐Michelle, et al.
Publicado: (2021)

AI-based dimensional neuroimaging system for characterizing heterogeneity in brain structure and function in major depressive disorder: COORDINATE-MDD consortium design and rationale
por: Fu, Cynthia H. Y., et al.
Publicado: (2023)

Establishing an EU-China consortium on traditional Chinese medicine research
por: Uzuner, Halil, et al.
Publicado: (2010)

Comparison of Electroencephalography (EEG) Coherence between Major Depressive Disorder (MDD) without Comorbidity and MDD Comorbid with Internet Gaming Disorder
por: Youh, Joohyung, et al.
Publicado: (2017)

Thymosin α1: a novel therapeutic option for patients with refractory chronic purulent rhinosinusitis
por: Dalm, Virgil, et al.
Publicado: (2013)

The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response
por: Biernacka, J M, et al.
Publicado: (2015)

The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response
por: Biernacka, J M, et al.
Publicado: (2016)

Adherence and Persistence Across Antidepressant Therapeutic Classes: A Retrospective Claims Analysis Among Insured US Patients with Major Depressive Disorder (MDD)
por: Keyloun, Katelyn R., et al.
Publicado: (2017)

Immunoregulatory and/or Anti-inflammatory Agents for the Management of Core and Associated Symptoms in Individuals with Autism Spectrum Disorder: A Narrative Review of Randomized, Placebo-Controlled Trials
por: Arteaga-Henríquez, Gara, et al.
Publicado: (2023)

MEASURING COGNITIVE FUNCTION IN MDD: EMERGING ASSESSMENT TOOLS
por: Russo, Manuela, et al.
Publicado: (2015)

The Impact of Negative Symptoms and Neurocognition on Functioning in MDD and Schizophrenia
por: Quek, Yue Feng, et al.
Publicado: (2021)

Pharmacogenomics of MDD as a Developing Field: Challenges and Opportunities
por: Baune, B.
Publicado: (2022)

Baseline Serum Levels of Beclin-1, but Not Inflammatory Factors, May Predict Antidepressant Treatment Response in Chinese Han Patients With MDD: A Preliminary Study
por: He, Shen, et al.
Publicado: (2019)

The role of inflammation in schizophrenia
por: Müller, Norbert, et al.
Publicado: (2015)

Cathodal tDCS Over Motor Cortex Does Not Improve Tourette Syndrome: Lessons Learned From a Case Series
por: Behler, Nora, et al.
Publicado: (2018)

Early improvement of painful symptoms in MDD: is there an association in achieving remission?
por: Bär, Karl-Jürgen
Publicado: (2007)

Relationship of Mean Platelet Volume To MDD: A Retrospective Study
Publicado: (2017)

The change of gut microbiota in MDD patients under SSRIs treatment
por: Shen, Yang, et al.
Publicado: (2021)

PTSD and comorbid MDD is associated with activation of the right frontoparietal network
por: Koopowitz, Sheri-Michelle, et al.
Publicado: (2023)

Editorial on EJPN focus section on E.U. paediatric MOG consortium consensus statements
por: Neuteboom, R.F., et al.
Publicado: (2020)

Cariprazine Use in Combination With a Mood Stabilizer in First Episode Mania
por: Palacios-Garrán, Roberto, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_t2dvfiut7k6f1l6vfbvsfcfobs